Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Not yet recruiting × Adrenal Insufficiency × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 16 Multiple Myeloma 6 Stomach Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Hepatocellular 5 Uterine Cervical Neoplasms 3 Recurrence 3 Ovarian Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Waldenstrom Macroglobulinemia 2 Venous Thromboembolism 2 Urinary Bladder Neoplasms 2 Thyroid Nodule 2 Stomatitis 2 Small Cell Lung Carcinoma 2 Skin Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Cancer Non-resectable 2 Neoplasms 2 Neoplasm Metastasis 2 Myasthenia Gravis 2 Lymphoma, B-Cell 2 Lymphoma 2 Gastric / Gastroesophageal Junction Adenocarcinoma 2 Febrile Neutropenia 2 Anemia 2

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡